DalCor Announces Launch of Dalcetrapib Clinical Trial for COVID-19
11 Jan 2021 //
GLOBENEWSWIRE
Dalcor taps new CEO Fouzia Laghrissi-Thode as pivotal PhIII looms
14 Apr 2018 //
ENDPTS
DalCor Randomizes First Patient in the DalGenE Phase 3 Cardiovascular Outcomes Tria
27 Apr 2016 //
PR NEWS WIRE
New cardiovascular drugs raise concerns about pricing, efficacy
21 Dec 2015 //
MMM
Merck seeks oasis in CETP inhibitor desert
18 Nov 2015 //
PHARMATIMES
Canadians hope $250 mln trial can revive failed Roche heart drug
11 Jun 2015 //
DAILY MAIL